US Biomax, Inc.

SKT1501

Skin cancer mid-density tissue array, 75 cases/150 cores

Microarray Panel:Skin carcinoma tissue microarray, containing 70 cases of skin diseases and carcinoma and 5 cases of normal,duplicated cores per case
Cores:150
Cases:75
Layout:15 cols × 10 rows
Core Diameter:1.1 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112131415
A Ski Ski Ear Vul Pen Nos Ear Nos Ski Nas Ski Hea Sca Hea Ski
B Ski Ski Ear Vul Pen Nos Ear Nos Ski Nas Ski Hea Sca Hea Ski
C Ski Sca Ski Sca Ski Hea Ski Foo Ing Ing Ing Pop Foo Lym Foo
D Ski Sca Ski Sca Ski Hea Ski Foo Ing Ing Ing Pop Foo Lym Foo
E Pen Ski Ski Pen Sca Ski Pen Ski Han Pen Ski Anu Ski Ski Pen
F Pen Ski Ski Pen Sca Ski Pen Ski Han Pen Ski Anu Ski Ski Pen
G Sca Pen Ski Ear Hea Nec Sca Fac Leg Nos Hea Eye Nos Upp Che
H Sca Pen Ski Ear Hea Nec Sca Fac Leg Nos Hea Eye Nos Upp Che
I Hea Foo Leg Ski Sca Che Hea Hea Ski Nec Leg Leg Che Ski Sca
J Hea Foo Leg Ski Sca Che Hea Hea Ski Nec Leg Leg Che Ski Sca
Legend: Anu - Anus, Che - Chest skin, Ear - Ear skin, Eye - Eye lip, Fac - Face skin, Foo - Foot, Han - Hand skin, Hea - Head skin, Ing - Inguinal lymph node, Leg - Leg skin, Lym - Lymph node, Nas - Nasal cavity, Nec - Neck lymph node, Nos - Nose, Pen - Penis, Pop - Popliteal fossa lymph node, Sca - Scalp, Ski - Skin, Upp - Upper lip, Vul - Vulva

- Benign tumor, - Malignant tumor, - Metastasis, - , - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 F 43 Skin Normal Normal
A2 2 M 42 Skin Normal Norma
A3 3 M 1 Ear skin Skin polyp Benign
A4 4 F 57 Vulva Warts (HPV+) Benign
A5 5 M 17 Penis Warts (HPV+) Benign
A6 6 M 73 Nose Papillomas Benign
A7 7 F 74 Ear skin Papillomas Benign
A8 8 M 38 Nose Papillomas Benign
A9 9 M 26 Skin Papillomas Benign
A10 10 M 42 Nasal cavity Papillomas Benign
A11 11 M 10 Skin Hemangioma Benign
A12 12 F 56 Head skin Hemangioma Benign
A13 13 F 57 Scalp Hemangioma Benign
A14 14 F 55 Head skin Hemangioma Benign
A15 15 F 1 Skin Hemangioma Benign
B1 16 F 43 Skin Normal Normal
B2 17 M 42 Skin Normal Norma
B3 18 M 1 Ear skin Skin polyp Benign
B4 19 F 57 Vulva Warts (HPV+) Benign
B5 20 M 17 Penis Warts (HPV+) Benign
B6 21 M 73 Nose Papillomas Benign
B7 22 F 74 Ear skin Papillomas Benign
B8 23 M 38 Nose Papillomas Benign
B9 24 M 26 Skin Papillomas Benign
B10 25 M 42 Nasal cavity Papillomas Benign
B11 26 M 10 Skin Hemangioma Benign
B12 27 F 56 Head skin Hemangioma Benign
B13 28 F 57 Scalp Hemangioma Benign
B14 29 F 55 Head skin Hemangioma Benign
B15 30 F 1 Skin Hemangioma Benign
C1 31 M 12 Skin Keratoacanthoma Benign
C2 32 F 21 Scalp Compound nevus Benign
C3 33 F 64 Skin Verrucous nevi Benign
C4 34 F 19 Scalp Compound nevus Benign
C5 35 M 9 Skin Junctional nevus Benign
C6 36 F 63 Head skin Seborrheic keratosis Benign
C7 37 F 37 Skin Junctional nevus Benign
C8 38 M 29 Footskin Melanoma Malignant
C9 39 F 40 Inguinal lymph node Melanoma Metastasis
C10 40 F 71 Inguinal lymph node Melanoma Metastasis
C11 41 M 48 Inguinal lymph node Melanoma Metastasis
C12 42 F 56 Popliteal fossa lymph node Melanoma Malignant
C13 43 M 25 Foot skin Melanoma Malignant
C14 44 M 77 Lymph node Melanoma Metastasis
C15 45 M 24 Foot skin Melanoma Malignant
D1 46 M 12 Skin Keratoacanthoma Benign
D2 47 F 21 Scalp Compound nevus Benign
D3 48 F 64 Skin Verrucous nevi Benign
D4 49 F 19 Scalp Compound nevus Benign
D5 50 M 9 Skin Junctional nevus Benign
D6 51 F 63 Head skin Seborrheic keratosis Benign
D7 52 F 37 Skin Junctional nevus Benign
D8 53 M 29 Footskin Melanoma Malignant
D9 54 F 40 Inguinal lymph node Melanoma Metastasis
D10 55 F 71 Inguinal lymph node Melanoma Metastasis
D11 56 M 48 Inguinal lymph node Melanoma Metastasis
D12 57 F 56 Popliteal fossa lymph node Melanoma Malignant
D13 58 M 25 Foot skin Melanoma Malignant
D14 59 M 77 Lymph node Melanoma Metastasis
D15 60 M 24 Foot skin Melanoma Malignant
E1 61 M 71 Penis Squamous cell carcinoma I T1N0M0 Malignant
E2 62 M 58 Skin Squamous cell carcinoma I T1N0M0 Malignant
E3 63 M 38 Skin Squamous cell carcinoma I T1N0M0 Malignant
E4 64 M 45 Penis Squamous cell carcinoma I T1N0M0 Malignant
E5 65 F 60 Scalp Squamous cell carcinoma I T1N0M0 Malignant
E6 66 M 54 Skin Squamous cell carcinoma I T2N0M0 Malignant
E7 67 M 63 Penis Squamous cell carcinoma I T1N0M0 Malignant
E8 68 M 60 Skin Squamous cell carcinoma I T1N0M0 Malignant
E9 69 M 45 Hand skin Squamous cell carcinoma I T2N0M0 Malignant
E10 70 M 63 Penis Squamous cell carcinoma I T2N1M0 Malignant
E11 71 F 75 Skin Squamous cell carcinoma I T3N0M0 Malignant
E12 72 M 68 Anus Squamous cell carcinoma I T1N0M0 Malignant
E13 73 M 53 Skin Squamous cell carcinoma II T1N0M0 Malignant
E14 74 M 67 Skin Squamous cell carcinoma II T2N0M0 Malignant
E15 75 M 74 Penis Squamous cell carcinoma II T1N0M0 Malignant
F1 76 M 71 Penis Squamous cell carcinoma I T1N0M0 Malignant
F2 77 M 58 Skin Squamous cell carcinoma I T1N0M0 Malignant
F3 78 M 38 Skin Squamous cell carcinoma I T1N0M0 Malignant
F4 79 M 45 Penis Squamous cell carcinoma I T1N0M0 Malignant
F5 80 F 60 Scalp Squamous cell carcinoma I T1N0M0 Malignant
F6 81 M 54 Skin Squamous cell carcinoma I T2N0M0 Malignant
F7 82 M 63 Penis Squamous cell carcinoma I T1N0M0 Malignant
F8 83 M 60 Skin Squamous cell carcinoma I T1N0M0 Malignant
F9 84 M 45 Hand skin Squamous cell carcinoma I T2N0M0 Malignant
F10 85 M 63 Penis Squamous cell carcinoma I T2N1M0 Malignant
F11 86 F 75 Skin Squamous cell carcinoma I T3N0M0 Malignant
F12 87 M 68 Anus Squamous cell carcinoma I T1N0M0 Malignant
F13 88 M 53 Skin Squamous cell carcinoma II T1N0M0 Malignant
F14 89 M 67 Skin Squamous cell carcinoma II T2N0M0 Malignant
F15 90 M 74 Penis Squamous cell carcinoma II T1N0M0 Malignant
G1 91 M 47 Scalp Squamous cell carcinoma II T2N0M0 Malignant
G2 92 M 68 Penis Squamous cell carcinoma II T2N1M0 Malignant
G3 93 M 49 Skin Squamous cell carcinoma II T2N0M0 Malignant
G4 94 F 72 Ear skin Squamous cell carcinoma II T1N0M0 Malignant
G5 95 M 72 Head skin Squamous cell carcinoma III T2N0M0 Malignant
G6 96 M 45 Neck skin Squamous cell carcinoma III T2N0M0 Malignant
G7 97 F 58 Scalp Squamous cell carcinoma III T1N0M0 Malignant
G8 98 F 57 Face skin Basal cell carcinoma Malignant
G9 99 M 70 Leg skin Basal cell carcinoma Malignant
G10 100 F 73 Nose Basal cell carcinoma Malignant
G11 101 F 45 Head skin Basal cell carcinoma Malignant
G12 102 M 68 Eye lip Basal cell carcinoma Malignant
G13 103 M 76 Nose Basal cell carcinoma Malignant
G14 104 M 65 Upper lip Basal cell carcinoma Malignant
G15 105 F 62 Chest skin Syringocarcinoma Malignant
H1 106 M 47 Scalp Squamous cell carcinoma II T2N0M0 Malignant
H2 107 M 68 Penis Squamous cell carcinoma II T2N1M0 Malignant
H3 108 M 49 Skin Squamous cell carcinoma II T2N0M0 Malignant
H4 109 F 72 Ear skin Squamous cell carcinoma II T1N0M0 Malignant
H5 110 M 72 Head skin Squamous cell carcinoma III T2N0M0 Malignant
H6 111 M 45 Neck skin Squamous cell carcinoma III T2N0M0 Malignant
H7 112 F 58 Scalp Squamous cell carcinoma III T1N0M0 Malignant
H8 113 F 57 Face skin Basal cell carcinoma Malignant
H9 114 M 70 Leg skin Basal cell carcinoma Malignant
H10 115 F 73 Nose Basal cell carcinoma Malignant
H11 116 F 45 Head skin Basal cell carcinoma Malignant
H12 117 M 68 Eye lip Basal cell carcinoma Malignant
H13 118 M 76 Nose Basal cell carcinoma Malignant
H14 119 M 65 Upper lip Basal cell carcinoma Malignant
H15 120 F 62 Chest skin Syringocarcinoma Malignant
I1 121 F 57 Head skin Syringocarcinoma Malignant
I2 122 F 20 Foot Dermatofibrosarcoma protuberans Malignant
I3 123 F 29 Leg skin Dermatofibrosarcoma protuberans Malignant
I4 124 F 41 Skin Dermatofibrosarcoma protuberans Malignant
I5 125 F 64 Scalp Plasmacytoma Malignant
I6 126 M 44 Chest skin Dermatofibrosarcoma protuberans Malignant
I7 127 M 75 Head skin Malignant fibrous histiocytoma Malignant
I8 128 M 11 Head skin Peripheral primitive neuroectodermal tumor Malignant
I9 129 F 35 Skin Nueroendocrine carcinoma Malignant
I10 130 M 57 Neck lymph node Non-Hodgkin's lymphoma Malignant
I11 131 M 81 Leg skin T cell lymphoma Malignant
I12 132 F 56 Leg skin T cell lymphoma Malignant
I13 133 F 81 Chest skin Metastatic breast carcinoma Metastasis
I14 134 F 48 Skin Metastatic adenocarcinoma Metastasis
I15 135 M 59 Scalp Metastatic hepatocellular carcinoma Metastasis
J1 136 F 57 Head skin Syringocarcinoma Malignant
J2 137 F 20 Foot Dermatofibrosarcoma protuberans Malignant
J3 138 F 29 Leg skin Dermatofibrosarcoma protuberans Malignant
J4 139 F 41 Skin Dermatofibrosarcoma protuberans Malignant
J5 140 F 64 Scalp Plasmacytoma Malignant
J6 141 M 44 Chest skin Dermatofibrosarcoma protuberans Malignant
J7 142 M 75 Head skin Malignant fibrous histiocytoma Malignant
J8 143 M 11 Head skin Peripheral primitive neuroectodermal tumor Malignant
J9 144 F 35 Skin Nueroendocrine carcinoma Malignant
J10 145 M 57 Neck lymph node Non-Hodgkin's lymphoma Malignant
J11 146 M 81 Leg skin T cell lymphoma Malignant
J12 147 F 56 Leg skin T cell lymphoma Malignant
J13 148 F 81 Chest skin Metastatic breast carcinoma Metastasis
J14 149 F 48 Skin Metastatic adenocarcinoma Metastasis
J15 150 M 59 Scalp Metastatic hepatocellular carcinoma Metastasis

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: